Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer

In recent years, the incidence of lung cancer has been increasing, and lung cancer has become the leading cause of cancer-related death. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. Platinum-containing chemotherapy is the first-line treatment for advanced patients. For pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haocheng, Yang, Xue, Sun, Yang, Li, Yanan, Dong, Ya, Shan, Dongfeng, Yu, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797489/
https://www.ncbi.nlm.nih.gov/pubmed/35117191
http://dx.doi.org/10.21037/tcr.2019.11.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797489/
https://www.ncbi.nlm.nih.gov/pubmed/35117191
http://dx.doi.org/10.21037/tcr.2019.11.09

Ejemplares similares